Correlation Between CONSOLIDATED and Conduit Pharmaceuticals
Specify exactly 2 symbols:
By analyzing existing cross correlation between CONSOLIDATED EDISON N and Conduit Pharmaceuticals, you can compare the effects of market volatilities on CONSOLIDATED and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CONSOLIDATED with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CONSOLIDATED and Conduit Pharmaceuticals.
Diversification Opportunities for CONSOLIDATED and Conduit Pharmaceuticals
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CONSOLIDATED and Conduit is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding CONSOLIDATED EDISON N and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and CONSOLIDATED is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CONSOLIDATED EDISON N are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of CONSOLIDATED i.e., CONSOLIDATED and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between CONSOLIDATED and Conduit Pharmaceuticals
Assuming the 90 days trading horizon CONSOLIDATED is expected to generate 14.8 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, CONSOLIDATED EDISON N is 19.05 times less risky than Conduit Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1.30 in Conduit Pharmaceuticals on September 3, 2025 and sell it today you would lose (0.03) from holding Conduit Pharmaceuticals or give up 2.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 65.31% |
| Values | Daily Returns |
CONSOLIDATED EDISON N vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| CONSOLIDATED EDISON |
| Conduit Pharmaceuticals |
CONSOLIDATED and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CONSOLIDATED and Conduit Pharmaceuticals
The main advantage of trading using opposite CONSOLIDATED and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CONSOLIDATED position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| CONSOLIDATED vs. Dave Busters Entertainment | CONSOLIDATED vs. Live Nation Entertainment | CONSOLIDATED vs. Broadstone Net Lease | CONSOLIDATED vs. World Houseware Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |